- Home
- / GL Biocontrol
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
GL Biocontrol financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
€711.4 K
FY, 2019
CreditSafe Score
?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 |
|---|---|---|
| Revenue | 522.3K | 711.4K |
| Cost of goods sold | 344.1K | 318.1K |
| Gross profit | 178.2K | 393.3K |
| Gross profit margin, % | 34.1% | 55.3% |
| General and administrative expense | 403.7K | 421.9K |
| Operating expense total | 412.5K | 429.9K |
| Depreciation and amortization | 2.7K | 2.5K |
| EBIT | 4.4K | 53.3K |
| EBIT margin, % | 0.8% | 7.5% |
| Interest income | 148.0 | 35.0 |
| Interest expense | 11.0 | |
| Pre tax profit | 4.6K | 53.3K |
| Income tax expense | 515.0 | (29.5K) |
| Net Income | 4.3K | 158.8K |